Navigation Links
Perrigo Reports Record Second Quarter Sales
Date:2/3/2009

- - - Common stock, shares issued 92,129 93,311 93,353 PERRIGO COMPANY CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (in thousands) (unaudited) Year-To-Date 2009 2008 Cash Flows (For) From Operating Activities Net income $62,951 $68,308 Adjustments to derive cash flows Write-off of in-process research and development 279 - Depreciation and amortization 34,362 30,983 Asset impairments 16,704 - Share-based compensation 4,923 3,930 Income tax benefit from exercise of stock options 646 2,094 Excess tax benefit of stock transactions (3,365) (3,209) Deferred income taxes (8,035) 1,908 Sub-total 108,465 104,014 Changes in operating assets and liabilities, net of asset and business acquisitions Accounts receivable (13,849) (22,125) Inventories (28,714) (24,238) Income taxes refundable (22,965) (4,568) Accounts payable 13,674 24,951 Payroll and related taxes (26,496) (2,605) Accrued customer programs (813) 664 Accrued liabilities (10,289) (
'/>"/>
SOURCE Perrigo Company
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine news :

1. Perrigo Company Announces Quarterly Dividend
2. Perrigo Company Appointed Generic Distributor by Medimetriks Pharmaceuticals
3. Perrigo Company Will Release Second Quarter Fiscal Year 2009 Results on February 3, 2009
4. Perrigo Company to Present at the 27th Annual JPMorgan Healthcare Conference
5. Perrigo Announces FDA Final Approval for Ibuprofen PM
6. Perrigo Settles Desloratadine Patent Litigation
7. Perrigo Acknowledges Settlement of NASACORT(R) AQ Nasal Spray Patent Litigation
8. Perrigo Announces FDA Tentative Approval for Ibuprofen PM
9. Perrigo Company Licenses Prescription Brands to Medimetriks Pharmaceuticals
10. Perrigo Company To Present at the Merrill Lynch Global Pharmaceutical Conference
11. Perrigo Begins Shipments of Famotidine Complete to Customers Nationwide
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... , ... August 28, 2015 , ... The newest therapy ... be available for general use any time soon, according to educational website Surviving Mesothelioma. ... therapy that received orphan drug designation for mesothelioma last week from the FDA, will ...
(Date:8/28/2015)... Indianapolis, IN (PRWEB) , ... August 28, 2015 ... ... employee benefits advisory organization, is pleased to welcome TJS Insurance Group as its ... to employees and clients guides them and keeps them focused on their goals. ...
(Date:8/28/2015)... ... ... External Counterpulsation, also known as ECP or EECP, is a proven treatment ... ECP) machines with a full clinic licence to help people prevent and reverse heart ... prevent and reverse heart disease through its evidence-based integrative approach to heart ...
(Date:8/28/2015)... ... August 28, 2015 , ... Yisrayl Hawkins, Pastor and ... and pleads for swift actions to be taken in order to ease the ... , Yisrayl says scientists have yet to understand fully the real cause of global ...
(Date:8/28/2015)... ... August 28, 2015 , ... Inc. magazine today ranked PREVENT Life ... of the nation’s fastest-growing private companies. The list was unveiled online at Inc.com and ... over the last three years, PREVENT ranks higher on the list than any other ...
Breaking Medicine News(10 mins):Health News:Surviving Mesothelioma Puts New Orphan Drug into Perspective in New Article 2Health News:TJS Insurance Group Is Latest Partner Firm To Join United Benefit Advisors 2Health News:TJS Insurance Group Is Latest Partner Firm To Join United Benefit Advisors 3Health News:Buy New External Counterpulsation (EECP or ECP) With Heart Fit Clinic 2Health News:Wake Up and Smell the Sick Atmosphere Says Yisrayl Hawkins in New Article This Week 2Health News:PREVENT Life Safety Ranks No. 3660 on the 2015 Inc. 5000 With Three-Year Sales Growth of 85% 2
... may be beneficial in preventing severe long-term disability in multiple ... treatment for the chronic progressive phase of MS, when serious ... Children's Hospital Boston study appearing in the Journal of Neuroscience, ... type of vitamin B3 known as nicotinamide cut the risk ...
... help reduce Alzheimer's disease, says a study on mice, but ... findings apply to people.// ,Jun Wang and other researchers ... mice with genes that order the production of amyloid-beta protein, ... reported the online edition of science magazine WebMD. ...
... the basic purpose of a sunscreen lotion as well as ... well on the threshold of a discovery; Scientists have found ... the fair skin people from tanning as well as guard ... David E. Fisher, director of the Melanoma Program at the ...
... 80% of people suffering from severe chronic lung disease ... of it.// ,Chronic Bronchitis and Emphysema constitute the ... lung tissue by smoking can lead to the development ... ,Professor Robert West, director of tobacco studies at Cancer ...
... particularly those with high levels of low-density lipoprotein ... according to a study in the September 20 ... specific class of lipoprotein particles found in human ... according to background information in the article. Studies ...
... kidney cancer has been rising over the last two decades, ... Center shows// that this increase is driven largely by the ... the rising incidence has been paralleled by greater use of ... fewer people dying. ,“With increased early detection and treatment ...
Cached Medicine News:Health News:Vitamin Shots to Combat MS Pain 2Health News:80% of lung disease remains ‘undiagnosed’. 2Health News:High Levels of Lipoprotein(a) in Women is Associated With Cardiovascular Risk 2Health News:More Kidney Cancer Is Detected and Treated Early, Yet Death Rate Rises 2Health News:More Kidney Cancer Is Detected and Treated Early, Yet Death Rate Rises 3
(Date:8/28/2015)... LONDRES, 28 de agosto de 2015   ... su participación en el  Congreso de la ESC ... más recientes y novedosas, entre ellas HeartModel A.I. ... las personas y la tecnología con los protocolos ... guiar los tratamientos y permitir atención en el ...
(Date:8/28/2015)... , August 28, 2015 ... to reach USD 49.12 billion by 2020, growing at ... to a new report by Grand View Research, Inc. ... CAGR of 49.7% from 2014 to 2020. ... aging population along with rising incidences of chronic diseases ...
(Date:8/27/2015)...  A recent study by Feucht et al, ... Arthrosurface HemiCAP® Wave implant, which is based on ... implant for isolated patellofemoral disease. While both implant ... scores, none of the patients in the "inlay" ... of the patients in the "onlay" group, showed ...
Breaking Medicine Technology:Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 2Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 3Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 4Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 5mHealth Market is Expected to Reach $49.12 Billion By 2020: Grand View Research, Inc. 2mHealth Market is Expected to Reach $49.12 Billion By 2020: Grand View Research, Inc. 3mHealth Market is Expected to Reach $49.12 Billion By 2020: Grand View Research, Inc. 4mHealth Market is Expected to Reach $49.12 Billion By 2020: Grand View Research, Inc. 5Study Demonstrates Dramatic Reduction in Progression of Osteoarthritis with the Arthrosurface "Inlay" Patellofemoral Implant Design Compared to Traditional "Onlay" Implant 2Study Demonstrates Dramatic Reduction in Progression of Osteoarthritis with the Arthrosurface "Inlay" Patellofemoral Implant Design Compared to Traditional "Onlay" Implant 3
... ELKRIDGE, Md., Dec. 8, 2011  Global performance improvement solutions ... subsidiary of GP Strategies Corporation (NYSE: GPX ... honored with a Platinum MarCom Award for Excellence in ... (Logo:  http://photos.prnewswire.com/prnh/20110404/MM77341LOGO-b ) ...
... today the launch of its new Posture+ sitting device, ... nearly 65 millions Americans traveling this holiday season. With ... their lifetime, this newest addition to the BackJoy product ... help travelers combat the problems associated with long-term sitting. ...
Cached Medicine Technology:GP's PerformTech Division Receives Prestigious MarCom Award 2GP's PerformTech Division Receives Prestigious MarCom Award 3BackJoy's Posture+ Device Aims to Rid the Holidays of Back Pain 2BackJoy's Posture+ Device Aims to Rid the Holidays of Back Pain 3
The Onyx® 9500 worlds first self-contained digital fingertip pulse oximeter incorporates the electronics and the sensor into one unit....
Ergonomically designed, the Invacare Printing Pulse Oximeter provides fast, reliable spot-check information and documentation of SpO2 and pulse rate. It is ideal for all patients from neonate to adul...
... The Invacare Digital Pulse ... and pulse strength. It is ... measurements on challenging patients. The ... other artifacts, informs the operator ...
Rad-9™...
Medicine Products: